Rula
Rula's behavioral health platform connects patients with insured therapists and psychiatrists, while also handling administrative tasks for its providers.
Secondary Market Price
Secondary Market Price
How Rula Measures Up
To help you manage your Rula equity, Prospect has run the company through our machine learning model.
Prospect Rating
2X
Our rating indicates that Rula has the potential to be worth at least double its current value in four years. For employees with stock, this suggests a moderate upside with the potential for their equity to double in value.
Exit Risk
Moderate Risk
Our Moderate Risk rating for Rula is based on the company scaling quickly and being backed by top investors, though its path to a liquidity event is less certain than that of the lowest-risk startups.
Funding Stage
Series B
Rula's Series B funding stage means it has a proven model and is now focused on significant expansion. This can be an ideal time to join, as it blends the opportunity for impact found at a startup with greater stability.
Secondary Market Price Chart
The secondary market prices for Rula shown here are a limited preview. Create a free account to access real-time secondary market prices
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Rula Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Rula's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Rula is a mental healthcare company that provides a platform connecting patients with therapists and psychiatric practitioners across the United States. The company offers therapy for individuals, couples, and families, in addition to psychiatric services, through its network of over 21,000 licensed providers. For these providers, Rula handles administrative tasks such as marketing, credentialing, and billing. Founded in 2019 as Path by Josh Bruno, Gabriel Diop, and Greg Moore, the company was initially focused on addiction care before expanding into a comprehensive behavioral health solution. Rula is headquartered in Los Angeles, California, and has grown to employ over 1,000 people.
The company aims to provide covered mental health services nationwide by 2025 and is scaling its operations to meet growing patient demand. A significant recent event was its Series C funding round on July 15, 2024, which raised $125 million, contributing to a total funding amount between $100 million and $200 million and a valuation between $1 billion and $3 billion. Rula has also recently entered into a partnership with Learn to Live, Inc. to expand access to in-network mental health care and has published peer-reviewed research on the effectiveness of real-world therapy.
- Icon Ventures
- Harmony Partners
- Upfront Ventures
- Blue Venture Fund
- GS Futures
- Four Rivers Group
- Tribe Capital
- Wing Venture Capital
- Co-Founder, CEO Josh Bruno
- Co-Founder, Gabriel Diop
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Rula worth joining?
Rula is a fast-growing behavioral healthcare company backed by top-tier investors and led by an experienced team. Deciding if it's the right fit depends on your personal career goals, and a platform like Prospect can help you evaluate the opportunity with data-driven insights into the company's potential.
What should I do with my Rula stock?
Managing equity in a private company like Rula involves complex decisions around exercising options and planning for taxes. Tools from Prospect can help you build a personalized strategy to optimize your equity's value and minimize your tax burden.
Can you sell Rula stock?
As Rula is a private company, its stock does not trade on public exchanges, but employees may have opportunities to sell shares during tender offers or on secondary markets. Platforms like Prospect provide tools to help employees navigate these liquidity events and determine which shares are most tax-optimal to sell.
How can I find the value of my Rula stock?
While Rula's latest valuation of $1B-$3B provides a high-level benchmark, the value of your specific shares can be harder to determine. You can use Prospect to get a more detailed estimate, as it uses predictive models and secondary market data to forecast your equity's potential worth.
What is Rula's equity worth?
Rula's most recent valuation places the company's worth between $1 billion and $3 billion. The value of an individual's equity stake depends on factors like the number of shares and potential dilution, which can be modeled using specialized equity management platforms like Prospect.
What is Rula's stock ticker symbol?
Rula Health is a privately held company and does not have a stock ticker symbol. Ticker symbols are only assigned to companies whose shares are traded on a public stock exchange.
Can I buy or sell Rula stock?
Since Rula is a private company, its stock is not available for purchase on public markets and can typically only be sold by employees during specific events like tender offers. When selling opportunities arise, resources like Prospect can help employees manage the process and optimize their financial outcome.
What is the criteria to buy or invest in Rula stock?
Investment in a private Series C company like Rula is generally limited to institutional venture capital firms and accredited investors participating in organized funding rounds. The company's shares are not available for purchase by the general public on any stock market.
